New York, New York-- (Newsfile Corp. - February 5, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, ...

The chip maker posted a big jump in revenue in its data-center business, but the results undershot analysts' r ...

The company that recently introduced the 60-minute foldable Baby Box also has another foldable tiny home with more creature ...

Congressional representatives push to ease regulatory hurdles for de novo banks, citing barriers to entry for small lenders.

Follow along for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen join 'Squawk Box' to discuss the company's quarterly ...

Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...

The results highlight an important physiological function of PGAM in the differentiation and suppressive activity of Treg cells by regulating serine synthesis. This role is proposed to intersect with ...

Box Cl A shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.

LVMH shares dropped as slightly better-than-expected full-year results from the world’s largest luxury company threw doubt ...

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...